A Phase III, Multicenter, Collaborative, Open-Label Clinical Trial of Sildenafil in Japanese Patients With Pulmonary Arterial Hypertension

Circulation Journal - Japan
doi 10.1253/circj.cj-10-0671
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Circulation Society

Related search

Sildenafil in Severe Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease: A Randomized Controlled Multicenter Clinical Trial

Journal of Heart and Lung Transplantation
CardiologyTransplantationCardiovascular MedicinePulmonaryRespiratory MedicineSurgery
2017English

Infliximab for Pediatric Patients With Ulcerative Colitis: A Phase 3, Open-Label, Uncontrolled, Multicenter Trial in Japan

BMC Pediatrics
Child HealthPediatricsPerinatology
2019English

Multicenter, Open-Label, Exploratory Clinical Trial With Rhodiola Rosea Extract in Patients Suffering From Burnout Symptoms

Neuropsychiatric Disease and Treatment
2017English

A Phase III, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Long-Term Triple Combination Therapy With Azilsartan, Amlodipine, and Hydrochlorothiazide in Patients With Essential Hypertension

Blood Pressure
Internal MedicineMedicineCardiovascular MedicineCardiology
2017English

Combining Bosentan and Sildenafil in Pulmonary Arterial Hypertension Patients Failing Monotherapy: Real-World Insights

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2015English

Safety and Efficacy of Intrarenal Arterial Autologous CD34+ Cell Transfusion in Patients With Chronic Kidney Disease: A Randomized, Open-Label, Controlled Phase II Clinical Trial

Stem cells translational medicine
MedicineDevelopmental BiologyCell Biology
2020English

Phase 2 and 3 Clinical Trials in Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2008English

Right Ventricular Reverse Remodelling After Sildenafil in Pulmonary Arterial Hypertension

Heart
Cardiovascular MedicineCardiology
2006English

PCN141 Quality of Life in Small Cell Lung Cancer: Results of an Open-Label Phase III Clinical Trial

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy